one
greatest
discoveri
medic
scienc
discoveri
sialic
acid
swedish
chemist
blix
separ
polyhydroxi
acid
part
disaccharid
crystallin
compound
isol
boil
water
solut
bovin
submaxillari
mucin
salivari
gland
propos
intern
call
sialic
acid
sia
greek
root
sialo
saliva
german
biochemist
klenk
purifi
brain
glycolipid
ganglion
cell
neuron
brain
gray
matter
call
gangliosid
call
acid
crystal
methanolysi
cleav
glycosid
linkag
gangliosid
neuramin
acid
neu
german
biochemist
gottschalk
found
watersolubl
nitrogencontain
compound
releas
ovomucinhuman
urinari
mucoprotein
incub
v
cholera
influenza
b
viru
report
nsubstitut
isoglucosamin
pathogen
enzym
releas
monosaccharid
name
receptordestroy
enzym
rde
accord
activ
burnet
stone
later
name
sialidas
propos
heimer
meyer
name
neuraminidas
na
propos
blix
gottschalk
klenk
final
appear
characterist
build
block
sia
nsubstitut
isoglucosamin
compound
found
hematamin
acid
hematosid
glycolipid
equin
blood
stroma
lactamin
acid
cow
colostrum
ident
neu
acid
acid
acid
neu
deamin
neu
isol
rainbow
trout
egg
polysialoglycoprotein
name
ketodeoxynonuloson
kdn
current
sia
fig
use
gener
name
famili
acid
sugar
deriv
backbon
deriv
neu
kdn
shown
fig
sia
modif
carbon
backbon
posit
give
four
core
molecul
neu
found
natur
form
due
side
effect
methanolysi
provok
denacyl
sia
common
deriv
kdn
four
core
molecul
carri
substitu
describ
legend
fig
natur
sia
exist
predominantli
sialylglycoconjug
n
olink
glycoprotein
well
gangliosid
cell
plasma
membran
fig
occasion
glycosylphosphatidylinositol
gpi
anchor
protein
well
secret
glycoprotein
neg
charg
sia
moieti
typic
found
outermost
end
glycoconjug
link
gal
galnac
found
glycoprotein
gangliosid
glcnac
glc
found
glycoprotein
gangliosid
second
sia
found
glycoprotein
gangliosid
less
often
gal
glcnac
found
glycoprotein
second
sia
found
glycoprotein
oligom
n
n
residu
found
far
jelli
coat
glycoprotein
sea
urchin
egg
figur
show
wellknown
sialylglycoconjug
recogn
virus
termin
sialyl
linkag
antenna
glycoconjug
remark
potenti
recognit
determin
endogen
sialyl
glycanbind
protein
lectin
mediat
variou
biolog
process
cell
signal
pivot
develop
mainten
life
function
exogen
lectin
variou
exogen
agent
bacteria
toxin
protozoa
virus
mediat
symbiot
pathogen
process
parasit
relationship
host
pathogen
drive
coevolutionari
arm
race
host
pathogen
result
divers
sia
exampl
human
evolv
mechan
inactiv
gene
encod
hydroxylas
convert
mammalian
cell
normal
adult
human
cell
found
less
total
sia
dietari
intak
loss
product
appear
render
human
cell
resist
pathogen
infect
infect
enterotoxigen
escherichia
coli
malaria
parasit
plasmodium
reichenowi
infect
pathogen
rapid
evolut
influenza
virus
abl
switch
bind
specif
includ
avid
specif
sia
speci
host
glycan
surfac
chang
amino
acid
bind
pocket
hemagglutinin
ha
lectin
besid
evas
pathogen
evolutionari
suppress
express
major
sia
critic
sever
endogen
function
seem
unfavor
abolish
product
mice
inactiv
udpglcnac
gne
key
enzym
biosynthesi
result
earli
embryon
lethal
mutat
gne
gene
human
result
impair
sialyl
oglycan
format
sarcolemm
glycoprotein
mechan
explain
muscular
diseas
call
distal
myopathi
rim
vacuol
sever
virus
caus
import
diseas
human
livestock
affect
health
larg
social
econom
burden
wherea
virus
use
therapeut
applic
oblig
intracellular
parasit
virus
must
invad
take
host
cellular
machineri
surviv
multipl
success
life
virus
must
pass
three
import
stage
entri
gene
express
genom
replic
exit
shown
fig
entri
stage
critic
surviv
continu
life
cycl
also
contribut
viru
transmiss
pathogenesi
stage
requir
specif
interact
viral
capsid
protein
nonenvelop
virus
viral
spike
glycoprotein
envelop
virus
specif
receptor
molecul
host
cell
surfac
viral
attach
chapter
focus
siabind
virus
characterist
lectin
interact
describ
design
develop
viral
detectionantivir
drugsvirusbas
therapi
discuss
abil
viru
bind
sia
determin
via
simpl
hemagglutin
test
incub
viru
siarich
erythrocyt
observ
erythrocyt
agglutin
hemagglutin
nake
eye
confirm
sia
oacetyl
sia
requir
viru
bind
virussiabind
inhibit
test
perform
use
erythrocyt
pretreat
na
enzym
bacterium
viru
cleav
termin
sia
residu
use
siadefici
cell
line
cell
specif
bind
viru
oacetyl
sia
check
use
erythrocyt
pretreat
oacetyl
esteras
viru
bovin
coronaviru
influenza
c
viru
cleav
oacetyl
group
sia
residu
hemagglutin
inhibit
perform
use
siacontain
compound
fetuin
competitor
reveal
role
sia
type
linkag
type
sequenc
composit
chain
length
architectur
bind
specif
virus
viral
lectin
direct
bind
virus
viral
lectin
varieti
defin
structur
sialyl
glycopolym
coat
micropl
print
microarray
slide
determin
quantit
detect
detect
perform
sever
method
measur
intens
fluoresc
product
viral
na
enzym
activ
measur
fluoresc
label
antiviralantivir
lectin
antibodi
fluoresc
label
virus
viral
lectin
correl
number
glycanbound
virus
viral
lectin
reveal
viral
glycan
interact
conform
divers
sialyl
ligand
bound
viral
lectin
xray
crystallographi
wide
use
techniqu
determin
atom
arrang
threedimension
space
cocryst
obtain
evapor
viral
lectin
sialyl
glycan
appropri
solvent
role
hemagglutin
activ
tickborn
thogoto
viru
remain
determin
five
genera
famili
orthomyxovirida
confirm
intern
host
cell
via
endocytosi
upon
bind
glycoprotein
target
sia
receptor
genu
contain
one
speci
infecti
salmon
anemia
isa
viru
isav
genu
isaviru
caus
system
lethal
diseas
farm
wild
salmonid
wherea
influenza
b
c
virus
genera
influenzaviru
b
c
respect
caus
influenza
contagi
respiratori
diseas
differ
sever
host
rang
shown
tabl
isav
separ
encod
hemagglutininesteras
fusion
f
glycoprotein
separ
initi
viral
attach
termin
glycan
via
hef
complex
attach
mediat
dissoci
f
viru
endocytos
host
cell
influenza
c
virus
encod
hemagglutininesterasefus
hef
glycoprotein
respons
receptor
bind
receptor
destroy
membran
fusion
influenza
b
virus
hemagglutinin
ha
glycoprotein
mediat
receptor
bind
membran
fusion
separ
neuraminidas
na
glycoprotein
possess
receptordestroy
function
hef
glycoprotein
influenza
c
virus
attach
sugar
chain
found
respiratori
tract
anim
receptor
determin
infect
cattl
pig
c
viru
detect
human
influenza
fig
b
virus
recogn
sugar
chain
caus
epidem
human
shown
tabl
howev
influenza
virus
wide
host
rang
anim
varieti
subtyp
due
high
mutat
rate
reassort
genom
segment
point
mutat
allow
quickli
adapt
new
environ
subtyp
report
use
specif
sia
receptor
key
determin
hosttissu
tropism
specif
avian
influenza
virus
primarili
recogn
mainli
found
bird
intestin
epitheli
cell
embryon
chicken
egg
chorioallanto
cell
humanadapt
pandem
season
influenza
virus
detect
nasal
nasopharyng
sampl
throat
swab
tracheal
bronchial
aspir
domin
infect
human
nonhuman
influenza
viru
cross
speci
barrier
via
via
intermedi
host
lead
pandem
far
four
pandem
report
pandem
pdm
unknown
origin
biochem
evolut
studi
indic
tha
ha
gene
pandem
deriv
nonhuman
virus
provid
major
viral
antigen
new
human
nonhuman
avian
av
ha
ha
chang
bind
prefer
receptor
predomin
region
human
respiratori
system
tracheal
epithelium
except
human
alveoli
region
receptor
domin
effici
transmiss
among
human
classic
ha
decreas
bind
found
porcin
respiratori
tract
rare
healthi
human
adult
host
nonhumantopandem
ha
lectin
acquir
sia
typelinkag
shift
bind
specif
pandemictoseason
longterm
humanadapt
drift
bind
prefer
long
glycan
presenc
lacnac
unit
human
respiratori
sialyl
nglycan
lacnac
unit
lacnac
structur
respons
total
human
alveolar
nglycan
might
anoth
factor
explain
season
virus
rare
found
human
alveoli
littl
known
isav
includ
potenti
spark
pandem
extens
studi
influenza
virus
indic
continu
threat
nonhuman
influenza
virus
especi
avian
swine
influenza
virus
human
infect
highlight
need
surveil
chang
receptor
bind
ha
amino
acid
receptor
bind
prefer
humantyp
receptor
famili
paramyxovirida
human
parainfluenza
viru
type
type
type
mump
viru
sendai
viru
newcastl
diseas
viru
ndv
shown
siabind
virus
unlik
virus
orthomyxovirida
fuse
envelop
host
endosom
membran
virus
nonseg
ssrna
genom
releas
host
cytosol
via
direct
fusion
host
plasma
membran
virus
undissoci
bind
destroyingreceptor
molecul
hemagglutininneuraminidas
hn
trigger
fusion
activ
f
protein
upon
bind
sialic
acidcontain
receptor
hn
demonstr
carri
two
siabind
site
result
obtain
comput
model
analysi
glycan
array
assay
suggest
bindingcatalyt
site
prefer
bind
site
ii
prefer
sulfat
agreement
result
earlier
studi
show
preferenti
bind
link
branch
lacnac
crystallograph
studi
hn
complex
reveal
site
receptor
bind
na
activ
locat
globular
head
hn
wherea
site
ii
receptor
bind
activ
near
hn
dimer
interfac
thought
involv
promot
viru
fusion
direct
receptor
bind
assay
show
bind
receptor
suggest
flexibl
bind
pocket
hn
similar
bind
prefer
shown
bind
cleav
ligand
glycan
array
howev
often
less
frequent
detect
caus
laryngotracheobronch
croup
children
wherea
caus
pneumonia
bronchiol
infant
studi
receptor
bind
patholog
observ
suggest
virus
might
target
differ
cell
type
differ
region
human
respiratori
system
thu
analysi
viru
cell
type
bind
specif
sialoglycoconjug
human
respiratori
system
age
group
need
unlik
target
abovedescrib
respiratori
virus
mump
viru
primarili
infect
parotid
salivari
gland
sometim
spread
tissu
organ
includ
pancrea
testi
ovari
mammari
gland
kidney
cocryst
structur
analysi
fig
glycanbind
assay
reveal
mump
viru
hn
protein
prefer
link
unbranch
sugar
chain
uncov
glycan
express
profil
infect
tissu
expand
understand
viru
tropism
control
due
similar
sequenc
structur
antigen
sendai
viru
socal
murin
parainfluenza
viru
primarili
infect
respiratori
tract
mice
laboratori
anim
includ
rat
hamster
guinea
pig
occasion
pig
sinc
agglutin
red
blood
cell
previous
known
hemagglutin
viru
japan
hvj
shown
bind
linear
branch
sialosylpolylactosamin
sialylpolylacnac
sequenc
erythroglycan
ii
erythrocyt
membran
gangliosid
includ
iactiv
iactiv
gangliosid
termin
fig
coat
asialoerythrocyt
resist
v
cholera
sialidasetr
cell
sendai
viru
infect
restor
fulli
resialyl
cell
cmpsia
indic
receptor
determin
sendai
viru
infect
research
work
clarifi
bind
prefer
interact
sendai
viru
sialyl
glycan
receptor
lead
gener
recombin
sendai
viru
specif
cell
type
improv
efficaci
specif
viru
entri
thu
safeti
therapeut
approach
virusbas
vaccin
human
respiratori
virus
viru
vector
reprogram
cell
genom
regen
medicin
oncolyt
virotherapi
cancer
ndv
minor
zoonosi
exposur
larg
amount
viru
necessari
human
infect
typic
caus
mild
conjunct
andor
influenzalik
symptom
ndv
mainli
infect
domest
poultri
caus
rang
diseas
nonappar
sever
respiratorygastrointestinalnerv
system
diseas
depend
viru
strain
neurovirul
strain
infect
infect
poultri
would
develop
pneumon
follow
enceph
lead
sever
econom
effect
poultri
product
henc
ndv
sometim
call
avian
pneumoenceph
base
laboratori
test
virul
mean
death
time
chicken
embryo
allanto
inocul
ndv
divid
three
group
velogen
virul
mesogen
midvirul
lentogen
nonvirul
velogen
strain
caus
econom
loss
lentogen
strain
use
vaccin
chicken
oncolyt
virotherapi
understand
ndv
attach
receptor
viral
entri
mechan
critic
find
way
control
viru
infect
inhibit
chicken
infect
velogen
strain
enhanc
entri
lentogen
strain
tumor
cell
earli
studi
show
ndv
prefer
either
gangliosid
contain
linear
lactoseri
type
oligosaccharid
gangliosid
either
neuac
neugc
recent
advanc
siaprotein
cocryst
techniqu
hemadsorptionfus
defici
dimer
interfac
mutant
reveal
ndv
hn
carri
two
siabind
activ
site
site
possess
receptor
bind
mediat
na
activ
trigger
hn
interact
f
protein
site
ii
receptor
bind
activ
dimer
interfac
propos
maintain
virushost
sia
attach
fusion
molecular
model
ndv
hn
small
molecul
analysi
bind
free
energi
interact
indic
site
prefer
site
ii
interact
similar
interact
much
weaker
interact
site
interest
bind
ndv
red
blood
cell
inhibit
increas
presenc
zanamivir
na
inhibitor
preferenti
bind
site
rais
import
question
whether
na
activ
requir
ndv
nh
bind
andor
fusion
whether
site
ii
work
independ
must
activ
site
bind
compound
zanamivir
question
answer
order
effici
control
function
two
site
famili
coronavirida
nonseg
ssrna
toroviru
coronavirus
genu
betacoronaviru
clade
group
clade
c
transmiss
gastroenter
coronaviru
tgev
genu
alphacoronaviru
tgev
discuss
famili
parvovirida
report
bind
sia
virus
use
spike
glycoprotein
multifunct
molecul
subunit
bind
receptor
subunit
contain
fusion
peptid
fp
fuse
viral
host
membran
activ
proteolyt
cleavag
fusion
virus
occur
endosom
membran
middl
east
respiratori
syndrom
coronaviru
merscov
mainli
fuse
viral
membran
plasma
membran
sinc
protein
sensit
activ
phdepend
endosom
proteas
host
secret
surfac
proteas
torovirus
caus
gastroenter
vertebr
mainli
cattl
pig
hors
human
especi
children
base
compar
sequenc
analysi
four
genotyp
classifi
equin
toroviru
bern
viru
eqtov
bovin
toroviru
breda
viru
btov
porcin
toroviru
markelo
viru
ptov
human
toroviru
htov
littl
known
receptor
bind
specif
toroviru
protein
evid
eqtov
lack
intact
hemagglutininesteras
gene
agglutin
human
rabbit
guineapig
erythrocyt
hemagglutin
decreas
presenc
fetuin
gangliosid
evid
suggest
glycoproteinsglycolipid
may
receptor
toroviru
protein
coronavirus
caus
varieti
ill
vari
sever
wide
rang
host
infect
mainli
associ
respiratori
diseas
especi
common
cold
human
infect
often
lead
diarrhea
anim
coronavirus
spark
global
concern
pandem
potenti
sinc
zoonot
transmiss
like
bat
human
sever
acut
respiratori
syndrom
sarscov
siabind
viru
via
civet
cat
intermedi
host
emerg
first
asia
sever
viral
respiratori
merscov
via
camel
intermedi
host
emerg
first
middl
eastern
countri
coronavirus
use
sia
receptorassist
receptorattach
factor
shown
tabl
protein
bovin
coronaviru
bcov
human
coronaviru
hcov
genu
betacoronaviru
clade
lineag
group
report
bind
sia
receptorbind
site
typic
betacoronavirus
also
carri
spike
protein
bind
oacetyl
sia
well
protein
present
torovirus
coronavirus
result
evolut
studi
suggest
intact
gene
present
three
genera
torovirus
btov
ptov
htov
betacoronaviru
clade
group
protein
bind
oacetyl
sialic
acid
acquir
via
independ
heterolog
rna
recombin
event
yet
unknown
sourc
possibl
mix
infect
anoth
viru
influenza
c
viru
variant
gene
becom
circul
strain
could
explain
find
protein
increas
effici
product
infecti
viru
possibl
act
lectin
enhanc
viral
bind
enzym
destroy
receptor
deoacetyl
esteras
enhanc
releas
trap
virion
host
mucosa
bud
virion
infect
cell
howev
clarifi
protein
protein
act
cooper
support
viru
infect
clarifi
whether
viru
still
infect
cell
receptor
bind
one
site
inhibit
understand
mechan
initi
infect
lead
develop
potenti
strategi
combat
viru
infect
protein
virus
differ
host
distinct
receptorsubstr
prefer
esteras
porcinebovin
torovirus
equinebovinehuman
coronavirus
specif
acid
esterasedefici
ptov
receptorbind
domain
bind
shown
fig
esteras
bovin
torovirus
prefer
dioacetyl
substrat
acid
bovin
coronaviru
also
bind
sia
rodent
coronavirus
express
rat
coronaviru
protein
bind
sia
protein
murin
coronaviru
dvim
diarrhea
viru
infant
mice
cleav
sia
viral
protein
may
flexibl
pocket
would
allow
greater
rang
receptorssubstr
pocket
protein
human
torovirus
shown
sequenc
ident
bovin
torovirus
lack
inform
regard
receptorsubstr
prefer
receptorbind
substratecleav
specif
protein
host
indic
viru
jump
infect
differ
anim
speci
protein
need
acquir
mutat
bindcleav
oacetyl
sia
express
host
target
merscov
genu
betacoronaviru
clade
c
bind
dipeptidyl
peptidas
also
call
primari
receptor
via
domain
b
subunit
bind
glycan
attach
factor
via
domain
subunit
spike
protein
design
ntermin
protein
bind
trigger
infect
noncili
bronchial
epitheli
cell
type
ii
pneumocyt
mainli
receptor
reduct
merscov
infect
sialidasetr
human
airway
cell
indic
host
sia
receptor
involv
determin
merscov
hosttissu
tropism
transmiss
remain
unclear
viru
emerg
infect
human
howev
mer
case
continu
report
indic
possibl
pandem
futur
highlight
need
continu
surveil
chang
merscov
includ
two
receptorbind
prefer
find
way
control
mer
sever
strain
list
tabl
small
ssrnacontain
virus
picornavirus
famili
picornavirida
includ
equin
rhiniti
viru
erav
genu
aphthoviru
enteroviru
enteroviru
coxsackieviru
variant
genu
enteroviru
encephalomyocard
viru
emcv
lowneurovirul
theiler
murin
encephalomyel
viru
tmev
genu
cardioviru
confirm
use
siacontain
receptor
host
cell
attach
erav
hors
pathogen
human
pathogen
emcv
wide
host
rang
includ
human
lowneurovirul
tmev
mous
pathogen
abl
caus
chronic
demyelin
diseas
thu
use
studi
human
multipl
sclerosi
shown
tabl
viral
capsid
picornavirus
compris
three
virion
protein
form
shell
one
virion
protein
lie
inner
surfac
viru
particl
illustr
fig
crystal
structur
viral
capsid
protein
complex
sialyl
ligand
shown
siabind
pocket
erav
pit
mainli
puff
b
lowneurovirul
tmev
analysi
emcv
mutantsvari
indic
amino
acid
respons
interact
sia
host
cell
surfac
typic
bind
viral
capsid
protein
picornavirus
receptor
trigger
endocytosi
endosom
becom
acid
viral
capsid
undergo
conform
chang
andor
proteas
activ
result
channel
format
allow
viral
genom
pass
host
cytosol
except
emcv
polioviru
remain
unclear
whether
genom
directli
penetr
plasma
membran
due
requir
low
ph
infect
inform
viru
strain
requir
sia
sialyl
glycan
structur
determin
viral
attach
infect
critic
understand
viru
tropism
pathogenesi
diagnosi
treatment
especi
design
detect
system
inhibitor
target
siabind
site
viral
lectin
erav
shown
requir
sia
host
cell
surfac
infect
reduct
viru
infect
host
cell
observ
sialidasetr
cell
use
ad
competit
receptor
bind
viru
sialyllactos
found
bind
erav
capsid
xray
crystallographi
residu
includ
interact
sia
conserv
across
erav
strain
impli
strain
erav
requir
sia
receptor
viru
entri
investig
role
sia
infect
six
strain
isol
patient
period
comparison
prototyp
fermon
strain
isol
year
ago
show
siadefici
cell
sialidasetr
cell
resist
infect
strain
clade
clade
b
clade
c
case
fermon
strain
sensit
infect
three
strain
clade
b
clade
clade
thu
classifi
siadepend
siaindepend
strain
respect
use
knockout
cell
line
gene
reconstitut
glycan
array
screen
infect
inhibit
assay
receptor
analogu
cocryst
structur
analysi
indic
either
lactos
lactosamin
receptor
viru
infect
possibl
explain
infect
caus
wide
spectrum
ill
although
still
major
caus
acut
hemorrhag
conjunct
ahc
epidem
worldwid
due
ocular
infect
conjunctiv
corneal
cell
still
potenti
spark
pandem
vaccin
antivir
drug
ahc
diseas
caus
knowledg
receptorbind
specif
virus
need
prevent
treatment
infect
viral
attach
studi
use
linkagespecif
sialidasetreatedsialidaseuntr
cell
sialidasetr
follow
cell
cell
block
lectin
suggest
prototyp
strain
bind
specif
linkag
host
cell
surfac
bind
phosphatidylinositolspecif
phospholipas
ctreat
cell
tunicamycintr
cell
benzyl
benzylgalnac
treat
cell
proteinas
ktreat
corneal
cell
suggest
prefer
bind
oglycosyl
nongpianchor
glycoprotein
human
corneal
epitheli
hce
cell
viral
bind
infect
studi
use
sialidas
pngase
f
tunicamycin
benzylgalnactreatedsialidas
pngase
f
tunicamycin
benzylgalnacuntr
cell
bind
competit
assay
presenc
sialyllex
tf
thomsenfriedenreich
suggest
bind
infect
hce
cell
via
olink
cell
surfac
protein
share
prefer
could
factor
explain
virus
overlap
cellular
tropism
bind
infect
conjunctiv
cell
ahccaus
human
picornavirus
must
investig
contrast
analysi
crystal
structur
complex
rang
sialyl
glycan
indic
bind
strongli
dslnt
fig
bind
weakli
lstc
sialyllex
fig
bind
suggest
bind
prefer
lstc
structur
confirm
bind
gangliosid
abil
bind
well
could
partial
explain
commonli
infect
human
upper
respiratori
tract
tissu
rich
termin
also
rich
mucintyp
oglycan
tear
film
could
facilit
spread
emerg
pandem
first
recognit
second
pandem
still
mysteri
two
pandem
caus
emerg
caus
ahc
outbreak
recent
investig
nonvari
variant
virus
use
essenti
receptor
infect
ahccaus
variant
hce
cell
significantli
depend
sialyl
cell
surfac
comparison
amino
acid
sequenc
siabind
pocket
nonvari
variant
virus
indic
nonvari
virus
first
variant
viru
contain
variant
virus
sinc
includ
pandem
viru
possess
bind
infect
hce
cell
wildtyp
viru
effici
bind
infect
cell
construct
mutant
find
suggest
viru
caus
ahc
still
unknown
enhanc
siabind
engag
chang
contribut
pandem
chang
respons
emerg
pandem
still
unknown
detail
sialyl
structur
use
emcv
attach
still
known
earlier
studi
show
wildtyp
mengoviru
avirul
mutant
agglutin
human
erythrocyt
via
bind
glycophorin
major
sialoglycoprotein
human
erythrocyt
emcv
strain
agglutin
human
equin
erythrocyt
domin
respect
agglutin
bovin
erythrocyt
domin
henc
select
agglutin
need
investig
investig
emcv
receptor
permiss
human
cell
reveal
strain
use
sialoglycoprotein
hela
cell
cell
surfac
receptor
viru
attach
rat
strain
parent
viru
siabind
viru
virus
cultur
babi
hamster
cell
produc
two
group
variant
group
becom
siadepend
bind
infect
primari
human
cardiomyocyt
effici
group
ii
siadepend
group
addit
rat
strain
appear
acquir
abil
replic
effect
buffalo
rat
liver
brl
cell
result
amino
acid
mutat
provid
abil
bind
sialyl
brl
cell
surfac
passag
find
indic
emcv
adapt
new
host
acquisit
abil
bind
sia
host
cell
surfac
cytopath
effect
cpe
caus
infect
lowneurovirul
tmev
strain
bean
da
cell
reduc
either
use
sialidasetr
cell
addit
medium
indic
import
sialyl
surfac
molecul
infect
persist
tmev
strain
singl
amino
acid
substitut
puff
b
bean
viru
caus
loss
reduct
viral
attach
erythrocyt
loss
reduct
viral
spread
among
cell
howev
mutant
viru
appear
recov
wildtyp
viru
potenti
bind
infect
prolong
passag
cell
suggest
mutant
acquir
rapid
adapt
host
environ
member
famili
calicivirida
cuplik
depress
viral
surfac
shown
siabind
virus
includ
human
enter
dijon
murin
enter
gv
norovirus
genu
noroviru
norwalklik
virus
rhesu
macaqu
enter
tulan
viru
tv
genu
recoviru
cat
respiratori
gi
felin
caliciviru
fcv
genu
vesiviru
porcin
enter
giii
cowden
sapoviru
psav
genu
sapoviru
sapporolik
virus
capsid
nonenvelop
virus
compris
u
singl
major
capsid
protein
dimer
form
monom
domain
shell
domain
protrus
p
domain
bind
p
domain
host
receptor
trigger
receptormedi
endocytosi
depend
clathrin
dynamin
ii
andor
cholesterol
shown
tabl
endocytosi
follow
penetr
viral
genom
host
cytosol
multipl
use
neoglycoprotein
bind
studi
reveal
viruslik
particl
vlp
dijon
norwalk
strain
bind
leb
h
type
chain
glycoconjug
dijon
strain
also
bind
sialyl
type
chain
glycoconjug
includ
sialyllex
sialyldilex
lex
sialyllea
indic
viru
bind
specif
later
analysi
bind
stoichiometri
nativ
mass
spectrometri
provid
evid
four
b
antigen
two
trisaccharid
form
complex
recombin
p
domain
dimer
variant
epitop
map
show
direct
interact
p
domain
bind
infect
primari
murin
macrophag
murin
noroviru
strain
reduc
presenc
either
sambucu
nigra
lectin
snl
preferenti
maackia
amurensi
lectin
mal
preferenti
sialidasetr
macrophag
use
enzymelink
immunosorb
assay
show
bound
gangliosid
addit
reduct
bind
infect
murin
macrophag
deplet
gangliosid
primari
murin
macrophag
restor
addit
similarli
role
also
observ
bind
infect
macrophag
murin
noroviru
strain
addit
interact
histoblood
group
antigen
hbga
tulan
viru
shown
bind
synthet
sialoglycoconjug
strongli
weakli
type
disaccharid
galnacg
tulan
viru
infect
permiss
cell
significantli
reduc
treatment
host
cell
either
na
snl
howev
investig
need
determin
hbga
sialoglycoconjug
coordin
attach
tulan
viru
mediat
infect
addit
felin
junction
adhes
moleculea
fjama
receptor
felin
caliciviru
fcv
reduct
fcv
bind
infect
v
cholera
na
treatment
host
cell
indic
sia
necessari
viru
bind
infect
fcv
bind
infect
also
reduc
snl
mal
indic
import
linkag
infect
furthermor
fcv
bind
infect
inhibit
presenc
tunicamycin
inhibit
nglycosyl
pngase
f
releas
nlink
oligosaccharid
presenc
benzylgalnac
inhibit
oglycosyl
find
indic
fcv
use
nlink
glycoprotein
primari
receptor
coreceptor
infect
attach
infect
psav
cowden
strain
markedli
inhibit
treatment
cell
v
cholera
na
partial
inhibit
treatment
cell
sialidas
mal
snl
suggest
viru
attach
infect
viru
bind
infect
reduc
treatment
cell
proteas
benzylgalnac
treatment
tunicamycin
pdmp
glucosylceramid
synthas
inhibitor
find
suggest
psav
cowden
strain
use
olink
glycoprotein
present
porcin
intestin
epitheli
cell
receptor
infect
interestingli
viru
agglutin
pig
human
rat
chicken
cow
red
blood
cell
bind
synthet
hbga
includ
h
type
known
express
pig
sialyl
sugar
chain
structur
found
red
blood
cell
membran
recogn
psav
cowden
strain
investig
detail
detail
inform
sialyl
glycan
recogn
viru
psav
mani
receptor
necessari
infect
lead
develop
effect
strategi
control
caliciviru
infect
nonenvelop
virus
contain
discret
segment
dsrna
multilay
capsid
belong
famili
reovirida
reo
deriv
respiratori
enter
orphan
virus
accord
patholog
first
member
found
respiratori
enter
tract
orphan
caus
symptomat
diseas
time
discoveri
virus
current
member
genu
orthoreoviru
true
reovirus
one
speci
genu
mammalian
orthoreovirus
also
call
reovirus
classifi
nonfusogen
virus
infecti
viru
particl
activ
clathrindepend
endosom
proteolysi
outer
shell
protein
result
capsid
conform
rearrang
exposur
hydrophob
part
viral
membranepenetr
protein
penetr
without
fuse
endosom
membran
host
cytosol
contain
three
serotyp
type
infect
varieti
mammalian
speci
includ
human
human
reovirus
usual
caus
subclin
mild
respiratori
ill
common
cold
enter
sometim
might
lead
sever
ill
tabl
includ
cn
diseas
infant
spread
infect
cn
reovirus
newborn
mice
also
shown
serotypespecif
type
spread
hematogen
infect
site
ependym
cell
produc
nonleth
hydrocephalu
wherea
type
spread
neutral
infect
neuron
result
lethal
enceph
type
studi
detail
due
difficulti
experiment
propag
serotypespecif
pattern
neurotrop
primarili
determin
viral
attach
protein
encod
viral
gene
ten
segment
dsrna
reovirus
divid
three
class
accord
size
three
segment
larg
three
medium
size
four
small
segment
encod
one
protein
except
gene
encod
structur
nonstructur
protein
denot
greek
letter
correspond
l
segment
encod
protein
number
protein
relat
segment
number
encod
exampl
gene
encod
protein
shown
fig
f
outer
shell
doubleshel
viru
compos
mainli
protein
includ
cleavag
product
protein
partli
homotrimer
spike
protein
interact
homopentamer
turretlik
spike
protein
vertex
vertic
viru
particl
serotypespecif
differ
rout
spread
recognit
differ
cell
cn
newborn
mice
thought
due
conserv
bind
locat
base
head
domain
virus
junction
adhes
moleculea
jama
differ
bind
specif
protein
virus
sialyl
glycan
earli
bind
specif
studi
reovirus
show
reoviru
hemagglutin
serotypespecif
type
preferenti
agglutin
human
erythrocyt
type
favor
bovin
erythrocyt
howev
detail
structur
sialyl
sugar
chain
erythrocyt
still
unknown
known
human
erythrocyt
higher
ratio
bovin
erythrocyt
detail
inform
siabind
specif
reovirus
obtain
use
glycan
array
screen
structur
studi
cocryst
recombin
protein
prototyp
type
strain
lang
prototyp
type
strain
dear
sialyl
glycan
glycan
array
analysi
bind
gangliosid
indic
bind
signal
stronger
bind
signal
appear
specif
decreas
type
type
infect
mous
embryon
fibroblast
crystal
structur
complex
show
termin
galnac
moieti
make
contact
protein
shallow
groov
globular
head
domain
crystal
structur
lack
termin
galnac
complex
fig
show
termin
trisaccharid
interact
contrast
crystal
structur
complex
trisaccharid
show
make
extens
contact
bodi
domain
homotrimer
protein
lactos
galglc
moieti
particip
contact
differ
direct
bodi
domain
presum
result
flexibl
three
bind
site
figur
show
termin
also
third
sugar
glc
direct
hydrogen
bond
bind
site
bind
site
also
accommod
either
propos
protein
reoviru
first
select
bind
specif
sialyl
glycan
host
cell
surfac
rel
low
affin
follow
bind
viral
protein
jama
host
cell
surfac
high
affin
firm
attach
viru
sialyl
glycan
jama
cell
surfac
mediat
viral
intern
via
clathrindepend
endocytosi
type
type
reovirus
also
caus
serotypespecif
pattern
infect
intestin
adult
mice
type
infect
crypt
epitheli
cell
patholog
restrict
ileum
type
prefer
goblet
absorpt
cell
caus
wide
patholog
duoden
jejun
ulcer
coliti
studi
reoviru
infect
rat
lung
indic
type
type
bind
linkag
infect
replic
type
alveolar
epitheli
cell
lead
pneumonia
type
produc
higher
titer
lung
type
wide
rang
bind
prefer
linkag
serotyp
specif
reovirus
cellular
tropism
respiratori
tract
includ
upper
respiratori
tract
may
exist
investig
need
understand
mechan
respons
differ
reoviru
serotyp
type
infect
potenc
cellular
tropism
pathogenesi
might
lead
develop
method
diagnosi
treatment
understand
might
also
use
improv
reovirus
clinic
therapeut
applic
cancer
chang
glycan
composit
profil
genu
famili
reovirida
member
attach
sia
effici
infect
genu
rotaviru
rotavirus
major
caus
viral
diarrhea
anim
worldwid
caus
death
half
million
infant
young
children
year
possess
dsrna
genom
segment
enclos
tripleshel
capsid
outer
shell
consist
glycoprotein
layer
protrud
dimer
spike
presenc
trypsin
serin
proteas
cleav
outer
shell
protein
shown
interact
sever
cell
surfac
molecul
bind
integrin
bind
integrin
heat
shock
cognat
protein
bind
sia
bind
requir
viru
strain
bind
integrin
sia
appear
straindepend
propos
top
molecul
initi
cell
attach
via
sia
interact
sequenti
altern
bodi
interact
integrin
foot
interact
follow
interact
outer
shell
layer
integrin
multistep
interact
final
trigger
endocytosi
via
mechan
depend
viru
strain
two
outer
shell
viral
protein
nonglycosyl
proteasesensit
protein
glycosyl
protein
carri
typespecif
epitop
also
use
classif
rotavirus
p
g
genotyp
respect
base
result
hemagglutin
test
hemagglutin
inhibit
test
infect
inhibit
test
na
treatmentblock
siacarri
inhibitor
inhibit
viru
bind
cell
enterocyt
andor
direct
interact
test
strain
p
genotyp
group
rotavirus
strain
group
c
rotaviru
shown
siadepend
virus
requir
bind
termin
sia
glycoconjug
host
cell
surfac
sensit
hydrolysi
na
therefor
siadepend
virus
subgroup
sialidasesensit
strain
two
human
strain
kun
genotyp
mo
test
found
siadepend
virus
requir
bind
intern
branch
sia
glycoconjug
ie
fig
bind
asialo
call
intern
branch
sia
gangliosid
appear
insensit
hydrolysi
na
therefor
siadepend
virus
subgroup
sialidaseresist
strain
later
infect
human
strain
wa
serotyp
preced
p
genotyp
parenthesi
bovin
strain
uk
shown
inhibit
cholera
toxin
b
ctb
infect
increas
use
cell
exogen
incorpor
use
sialidasetr
cell
increas
level
thu
human
bovin
rotavirus
p
genotyp
classifi
siadepend
virus
subgroup
sialidaseresist
strain
surprisingli
infect
porcin
strain
sialidasesensit
strain
reduc
ctb
treatment
thu
viru
classifi
sialidasesensit
strain
bind
termin
sia
intern
sia
shown
tabl
bind
prefer
rotavirus
sia
speci
determin
directli
indirectli
infect
human
sialidaseresist
strain
wa
sialidasetr
cell
reduc
presenc
suggest
sia
speci
prefer
strain
studi
inhibit
rotaviru
bind
host
cell
inhibit
rotaviru
infect
antibodi
analysi
crystallograph
structur
complex
reveal
protein
porcin
sialidasesensit
strain
osu
ym
bovin
strain
ncdv
carri
small
residu
greater
specif
hold
extra
hydroxyl
group
wherea
rhesu
simian
nasensit
strain
rrv
carri
higher
prefer
bovin
sialidaseresist
strain
uk
favor
shown
viru
acquir
mutat
decreas
affin
cultiv
cell
indic
viru
adapt
host
cell
surfac
receptor
recent
studi
sialyl
linkagespecif
sialidasesensit
rotaviru
strain
demonstr
infect
bovin
strain
ncdv
genotyp
canin
strain
decreas
snl
mal
infect
porcin
strain
inhibit
snl
mal
pretreat
cell
either
pdmp
inhibit
glucosylceramid
synthas
tunicamycin
inhibit
nglycosyl
inhibit
infect
virus
contrast
pretreat
benzylgalnac
inhibit
oglycosyl
affect
viru
infect
result
suggest
bovin
ncdv
canin
strain
bind
prefer
gangliosid
nlink
glycoprotein
porcin
strain
bind
gangliosid
nlink
glycoprotein
rotaviru
vaccin
avail
still
lack
antivir
drug
treatment
receptorbind
specif
rotavirus
could
use
design
effect
inhibitor
attach
initi
step
infect
human
adenovirus
hadv
belong
genu
mastadenoviru
mammalian
famili
adenovirida
mediums
nm
nonenvelop
virus
linear
dsdna
genom
type
recent
identifi
current
identifi
hadv
type
group
speci
g
type
speci
associ
human
ocular
diseas
type
current
member
speci
g
associ
gastroenter
thought
use
sia
primari
receptor
tabl
shown
fig
viral
capsid
hadv
construct
hexon
trimer
penton
pentam
project
long
fiber
trimer
outward
vertex
fiber
trimer
carri
receptorbind
site
monomer
distal
globular
end
knob
domain
bind
primari
receptor
host
cell
surfac
primari
bind
allow
penton
pentam
make
contact
secondari
receptor
host
cell
surfac
lead
endocytosi
typic
via
clathrin
howev
shown
endocytosi
human
adenoviru
type
speci
corneal
cell
use
protein
cluster
lipid
raft
base
reduct
fiber
knobviru
bind
infect
sialidasetr
cell
type
ocular
pathogen
hadv
speci
includ
natur
intertyp
recombin
hadv
type
believ
variant
strain
formal
known
natur
recombin
hadv
type
p
prototyp
far
shown
use
sia
primari
cellular
receptor
bind
mediat
trimer
fiber
knob
pretreat
cell
na
reduc
interact
caus
eye
infect
affect
product
infect
suggest
sia
may
support
viru
attach
use
function
receptor
viru
infect
xray
crystallograph
studi
shown
fiber
knob
two
differ
amino
acid
bind
indic
sialyllactos
determin
tropism
virus
glycan
array
screen
show
knob
domain
specif
bind
glycan
disialyl
branch
hexasaccharid
surfac
plasmon
reson
analysi
reveal
glycan
bind
knob
higher
affin
kd
bind
sialyllactos
knob
kd
mm
presum
two
termin
sia
singl
glycan
directli
interact
two
three
bind
site
trimer
knob
fig
indic
molecular
model
nuclear
magnet
reson
xray
crystallograph
studi
sever
experi
indic
bind
cell
surfac
olink
glycoprotein
rather
gangliosid
exampl
neither
reduct
gangliosid
biosynthesi
treatment
compound
remov
cell
surfac
nglycan
treatment
pngase
f
affect
bind
hce
cell
reduct
olink
glycan
synthesi
treatment
benzylgalnac
effici
inhibit
bind
hce
cell
infect
cell
thu
olink
glycoprotein
carri
glycan
mimic
glycan
function
host
receptor
amino
acid
sequenc
analysi
reveal
fiber
knob
ident
suggest
possess
bind
pocket
preferenti
bind
olink
glycoprotein
bear
glycan
fiber
knob
carri
amino
acid
differ
fiber
knob
identifi
determin
posit
amino
acid
structur
fiber
knob
screen
receptorbind
specif
use
viru
overlay
protein
blot
assay
shown
interact
human
conjunctiv
chang
c
membran
protein
approxim
molecular
weight
kda
car
calciumindepend
manner
chang
c
membran
protein
molecular
weight
kda
membran
protein
later
identifi
calciumdepend
manner
chang
c
membran
protein
molecular
weight
kda
sialyl
protein
calciumdepend
manner
pretreat
chang
c
cell
anticar
antibodi
littl
effect
infect
indic
infect
use
car
infect
chang
c
conjunctiv
cell
pretreat
chang
c
cell
na
led
abolish
bind
protein
affect
bind
protein
infect
find
suggest
bind
infect
conjunctiv
cell
protein
independ
sia
typic
hadv
one
type
fiber
trimer
enter
hadv
includ
speci
f
contain
speci
g
contain
two
differ
type
fiber
trimer
long
short
three
virus
use
longer
fiber
attach
coxsacki
adenoviru
receptor
car
target
cell
howev
short
fiber
bind
sia
short
fiber
shown
attach
specif
sia
appear
requir
either
car
sia
viru
infect
remov
host
cell
surfac
sia
na
treatment
abolish
bind
infect
siaexpress
origin
chines
hamster
ovari
cho
cell
abolish
partli
reduc
viru
bind
cho
cell
also
express
car
carexpress
cho
cell
compar
origin
cho
cell
show
remark
increas
bind
carexpress
cho
cell
thu
may
use
long
short
fiber
knob
knob
attach
host
car
andor
sia
primari
receptor
coprimari
receptor
initi
viru
infect
howev
sever
question
need
answer
understand
mechan
viru
infect
exampl
three
known
enter
hadv
two
spike
fiber
hadv
need
one
primari
receptorbind
spike
short
fiber
hadv
speci
f
bind
sia
like
short
fiber
speci
g
protein
carbohydr
possibl
receptor
target
gastrointestin
epitheli
cell
especi
lumin
apic
surfac
site
adenoviru
infect
identifi
sialyl
glycan
structur
preferenti
bind
determin
glycan
microarray
screen
use
varieti
probe
show
sever
probe
one
two
linkag
bound
short
fiber
knob
probe
linkag
significantli
detect
bind
strongest
bind
observ
probe
type
ii
backbon
sequenc
howev
use
broader
rang
probe
includ
linkag
glycan
microarray
screen
bind
specif
indic
interact
preferenti
linear
oligosia
polysia
especi
degre
polymer
produc
strong
bind
signal
much
greater
produc
linkag
sinc
polysia
abund
brain
lung
cancer
molecular
relationship
gastroenter
bind
specif
polysia
receptor
remain
unknown
determin
glycosyl
type
requir
viru
bind
reveal
inhibit
olink
glycosyl
inhibit
glycolipid
nlink
glycosyl
result
reduct
viru
particl
bind
cell
suggest
olink
glycan
play
major
role
bind
specif
nonhuman
adenovirus
shown
interact
sia
canin
adenoviru
type
caus
respiratori
diseas
dog
group
genu
mastadenoviru
mammal
turkey
adenoviru
type
virul
form
known
turkey
hemorrhag
enter
viru
thev
caus
hemorrhag
enter
turkey
splenomegali
chicken
marbl
spleen
diseas
pheasant
avirul
form
use
vaccin
previous
group
subgroup
ii
avian
adenovirus
current
group
speci
turkey
siadenoviru
genu
siadenoviru
amphibian
dinosauria
testudin
speci
crystallograph
studi
show
fiber
knob
bind
car
differ
bind
site
howev
bind
fiber
knob
highli
sialyl
glycophorin
detect
hemagglutin
correl
well
express
car
erythrocyt
agglutin
rat
human
erythrocyt
high
car
level
agglutin
erythrocyt
dog
mice
rabbit
lemur
monkey
undetect
level
car
thu
car
erythrocyt
like
import
factor
bind
glycan
microarray
analysi
fiber
knob
virul
avirul
strain
shown
interact
bind
isotherm
titrat
calorimetri
show
bind
affin
fiber
knob
head
mm
rang
ph
less
ph
two
fourfold
higher
affin
avirul
fiber
knob
appear
bind
strongli
sialyllactos
virul
fiber
knob
crystallograph
studi
show
siabind
region
fiber
head
compris
amino
acid
posit
two
amino
acid
differ
virul
avirul
fiber
head
domain
posit
hydrophob
hydrophil
virul
fiber
head
substitut
hydrophob
carri
long
side
chain
sulfur
atom
avirul
fiber
head
two
amino
acid
protein
surfac
separ
region
differ
siabind
region
region
may
bind
region
differ
ligand
car
possibl
respons
virul
avirul
pathogenesi
need
investig
presenc
multireceptorbind
site
fiber
knob
head
adenovirus
fiber
knob
contain
bind
site
sia
car
taken
consider
design
antivir
role
multireceptorbind
site
life
cycl
adenovirus
also
need
understood
effici
control
pathogen
virus
also
design
effici
vector
gene
therapi
develop
oncolyt
virotherapi
cellspecif
tropism
dependovirus
autonom
parvovirus
parvovirina
subfamili
famili
diamet
small
nonenvelop
virus
linear
ssdna
genom
parvovirida
found
bind
sia
probabl
due
small
amount
genet
materi
code
necessari
biochem
apparatu
indic
name
effici
replic
ssdna
dependovirus
except
duck
goos
parvovirus
depend
larger
helper
viru
adenoviru
herpesviru
papillomaviru
thu
nicknam
replicationdefect
parvovirus
adenoassoci
virus
aav
ssdna
autonom
parvovirus
autonom
replic
insid
cell
dna
synthesi
phase
host
cell
cycl
due
simpl
viral
genom
although
replicationdefect
parvovirus
report
caus
patholog
replicationautonom
parvovirus
found
nonpathogen
pathogen
member
bind
parvoviru
one
plasma
membran
receptor
initi
viru
infect
typic
via
clathrinmedi
endocytosi
possibl
breach
lipolyt
activ
phospholipas
locat
ntermin
uniqu
region
lead
releas
transport
capsid
andor
viral
dna
cytosol
nucleu
receptor
bind
function
viral
capsid
protein
cp
shown
fig
depend
viru
strain
matur
stage
cp
compris
two
four
overlap
capsid
protein
call
sixti
copi
subunit
cp
assembl
build
icosahedr
capsid
surround
parvoviru
form
altern
splice
messeng
rna
mrna
entir
sequenc
encod
within
gene
virus
third
structur
protein
form
dnacontain
capsid
cleavag
peptid
amino
terminu
shown
fig
vp
isoform
shorten
nterminu
vp
thu
contain
ctermin
amino
acid
receptorbind
region
arisen
altern
splice
cleavag
mrna
lack
ntermin
uniqu
region
critic
releas
viru
endosom
like
produc
posttransl
cleavag
ntermin
amino
acid
respect
produc
much
lower
copi
number
howev
major
capsid
compon
seem
final
product
posttransl
cleavag
shown
fig
adenoassoci
viral
capsid
consist
fulllength
vp
protein
lack
lack
nuclear
local
signal
nl
ratio
around
vp
contain
receptorbind
site
differ
role
bind
receptor
seem
involv
trigger
conform
chang
region
lead
exposur
phospholipas
domain
capsid
interior
critic
viral
infect
mention
differ
role
receptorbind
region
present
investig
detail
receptor
host
cell
plasma
membran
carbohydr
protein
investig
mani
virus
famili
focu
sia
receptor
recogn
viral
capsid
protein
especi
adenoassoci
virus
extens
studi
shown
tabl
autonom
parvovirus
bovin
parvoviru
bpv
porcin
parvoviru
ppv
known
bind
olink
either
olink
nlink
sialic
acid
respect
cell
surfac
attach
bind
canin
parvoviru
cpv
felin
panleukopenia
viru
fpv
canineadapt
form
emerg
cat
seem
cell
infect
though
bind
prefer
differ
sia
type
cpv
specif
fpv
specif
seem
determin
host
adapt
dog
cat
respect
evolut
appear
bind
cpv
sia
drift
neutral
ph
acid
ph
associ
mutat
viru
variant
cpv
type
emerg
replac
strain
global
fpv
transmit
oronas
rout
caus
preferenti
bind
sia
ph
assum
allow
attach
viru
progeni
releas
infect
progenitor
cell
crypt
intestin
epithelium
sia
materi
mucu
intestin
lumen
ph
around
bind
suggest
enhanc
viru
shed
stool
persist
environ
transmiss
host
exampl
siabind
viral
lectin
cpv
fpv
evolv
infect
target
cell
anoth
siabind
viral
lectin
use
viru
infect
spike
protein
sever
strain
transmiss
gastroenter
viru
tgev
linear
ssrna
envelop
viru
genu
alphacoronaviru
famili
coronavirida
caus
fatal
diarrhea
newborn
piglet
bind
specif
protein
thought
allow
viru
persist
pass
unfavor
environ
environ
low
ph
proteas
bile
salt
travel
alimentari
tract
target
site
intestin
epithelium
sia
appear
import
infect
minut
viru
mice
mvm
parvoviru
isol
human
tumor
cell
line
transplant
rat
autonom
rodent
parvovirus
infect
propag
kill
tumor
cell
nontransform
cell
thu
promis
antitumor
agent
siabind
site
play
determin
role
cellular
tropism
two
virus
thu
import
tumor
select
oncotrop
studi
shown
chang
amino
acid
residu
siabind
site
affect
receptorbind
prefer
probabl
lead
chang
host
rang
expandedrestrictedretarget
exampl
construct
recombin
mvmp
p
prototyp
strain
virus
vp
andor
substitut
near
siaposit
dimpl
accord
substitut
lethal
mvm
variant
deriv
infect
sever
combin
immunodefici
scid
mice
apathogen
strain
mvmp
report
lower
affin
sia
receptor
produc
largeplaqu
phenotyp
cell
line
vitro
caus
lethal
diseas
scid
mice
studi
indic
lower
sia
receptorbind
affin
viru
lead
extens
viral
tropism
dramat
increas
viral
pathogen
also
suggest
viru
variant
gener
via
genet
engin
natur
select
rais
seriou
concern
whether
use
oncolyt
virus
especi
immunosuppress
patient
safe
whether
viru
variant
caus
sever
diseas
may
emerg
oncovirotherapi
virotherapeut
formul
guarante
genet
stabil
may
requir
contrast
autonom
parvovirus
adenoassoci
virus
aav
report
caus
diseas
gener
low
level
immunogen
toxic
infect
divid
nondivid
cell
long
persist
sitespecif
integr
host
cell
genom
episom
state
gene
part
requir
chromosom
integr
remov
linear
ssdna
although
aav
replicationdefect
parvovirus
aav
wide
use
viral
vector
carri
therapeut
gene
gene
therapi
variou
disord
helper
gene
adenoviru
mediat
aav
replic
may
insert
plasmid
directli
insert
aav
vector
howev
immun
respons
aav
transduct
sometim
observ
lead
limit
use
aav
vector
exampl
unexpect
liver
toxic
occur
transduc
hepatocyt
clinic
gene
therapi
trial
hemophilia
b
due
cytotox
tlymphocyt
ctl
activ
capsid
heparin
bind
motif
indic
addit
develop
increas
aav
genom
capac
enhanc
gene
express
understand
aavhuman
host
interact
need
develop
highli
effici
transduct
specif
target
cell
immun
normal
cell
aav
ubiquit
serotyp
differ
capsid
structur
far
identifi
human
nonhuman
primat
sourc
like
parvovirus
viral
capsid
protein
cp
shown
fig
use
bind
cell
surfac
receptor
mediat
viral
entri
thu
prime
determin
host
rang
host
specif
bind
termin
sia
viral
capsid
siabind
motif
found
cp
compon
differ
bind
prefer
asialo
portion
includ
glycosid
linkag
type
shown
tabl
requir
oglycan
wherea
preferenti
bind
either
nglycan
bind
either
although
close
relat
residu
total
amino
acid
residu
differ
vp
appear
addit
bind
neg
charg
heparan
sulfat
proteoglycan
hspg
made
possibl
singl
amino
acid
differ
posit
indic
fig
coreceptor
found
necessari
optim
aav
attach
intern
plateletderiv
growth
factor
receptor
pdgfr
coreceptor
epiderm
growth
factor
receptor
egfr
coreceptor
addit
primari
receptorbind
region
coreceptorbind
site
identifi
sitespecif
modif
primari
coreceptorbind
site
aav
capsid
therapeut
applic
transduct
effici
natur
aav
serotyp
major
tissu
investig
result
summar
tabl
show
differenti
tropism
aav
serotyp
bovin
adenoassoci
viru
baav
nonprim
aav
use
sia
glycosphingolipid
gangliosid
receptor
transduct
infect
shown
baav
inject
via
canalostomi
effici
deliv
gene
control
gene
express
connexin
lead
rescu
gap
junction
coupl
cochlear
nonsensori
cell
inner
ear
adult
mice
nonsyndrom
hear
loss
deaf
phenotyp
although
persist
baavmedi
gene
replac
cochlea
remain
limit
result
studi
indic
baav
develop
recombin
viral
vector
gene
therapi
taken
togeth
result
indic
receptor
express
pattern
host
cell
surfac
vari
differ
host
cell
membran
also
differ
stage
cell
differenti
matur
extens
analysi
identif
host
receptor
express
pattern
togeth
studi
aav
bind
specif
receptor
target
tissu
cell
nontarget
immun
cell
could
lead
success
ration
modif
aav
capsid
specif
receptor
found
cell
target
tissu
immun
cell
construct
aav
vector
could
increas
transduct
efficaci
specif
desir
tissu
overcom
concern
advers
side
effect
includ
induct
immun
respons
typic
infect
virus
famili
polyomavirida
asymptomat
howev
virus
caus
diseas
especi
immunocompromis
individu
sever
kidney
brain
disord
caus
human
john
cunningham
polyomaviru
jcpyv
skin
cancer
call
merkel
cell
carcinoma
mcc
caus
merkel
cell
polyomaviru
mcpyv
tabl
also
bk
polyomaviru
bkpyv
reactiv
caus
nephropathi
renal
transplant
recipi
addit
polyomavirus
poli
mani
tumor
transform
cell
cultur
immunocompromis
laboratori
anim
includ
newborn
mice
surprisingli
simian
viru
monkey
viru
accident
introduc
human
contamin
polio
vaccin
abl
transmit
among
human
recent
detect
varieti
human
cancer
increas
number
detect
human
anim
polyomavirus
rais
concern
polyomavirus
might
acquir
mutat
andor
recombin
human
polyomavirus
potenti
caus
diseas
cancer
infect
host
cell
polyomaviru
nonenvelop
dna
viru
must
bind
receptor
host
plasma
membran
trigger
caveolaeraftmedi
endocytosi
clathrinmedi
endocytosi
jcpyv
navig
er
deliveri
dna
genom
nucleu
transcript
replic
fig
note
caveolinclathrinindepend
pathway
observ
polyomavirus
entri
bkpyv
primari
human
renal
proxim
tubul
epitheli
cell
viral
capsid
protein
respons
engag
host
cell
receptor
import
step
determin
cellular
tropism
pathogenesi
viru
intern
jcpyv
cell
via
clathrinmedi
endocytosi
unlik
relat
polyomavirus
includ
murin
polyomaviru
mpi
caus
tumor
newborn
mice
shown
tabl
bkpyv
mcpyv
suggest
jcpyv
receptorbind
prefer
differ
relat
polyomavirus
jcpyv
prefer
neolactoseri
nlink
glycoprotein
bind
serotonin
receptor
seem
facilit
endocytosi
pathway
mpi
bkpyv
either
caveolindepend
caveolinindepend
entri
share
common
bind
ganglioseri
gangliosid
differenti
bind
prefer
prefer
branch
gangliosid
mpyv
mainli
attach
bkpyv
mcpyv
commonli
prefer
bind
bseri
gangliosid
includ
bkpyv
cooper
bind
glycosaminoglycan
gag
mcpyv
comparison
crystal
structur
bkpyv
fig
sitedirect
mutagenesi
studi
provid
import
evid
amino
acid
posit
respons
differ
linkag
prefer
two
virus
thu
act
determin
receptor
specif
use
distinct
receptor
initi
viru
infect
contribut
differ
viru
hosttissuecel
tropism
patholog
consequ
shown
tabl
virus
rapidli
adapt
environ
although
polyomavirus
circular
dsdna
virus
use
host
polymeras
transcript
replic
progress
multifoc
leukoencephalopathi
pml
mutant
strain
jcpyv
detect
mutat
near
apic
siabind
pocket
possibl
result
posit
select
pml
develop
complet
blockag
attach
pmlmutant
viruslik
particl
partial
reduct
bind
wildtyp
jcpyv
genotyp
either
sft
cell
gliosarcoma
cell
larg
antigen
art
cell
ovarian
cancer
cell
larg
antigen
heparin
gag
observ
find
togeth
result
experi
includ
experi
infect
presenc
variou
treatment
inhibit
engag
gag
sialyl
receptor
indic
wildtyp
jcpyv
strain
use
either
gag
sialyl
glycan
infect
mutant
jcpyv
strain
lost
abil
bind
sialyl
glycan
use
gag
altern
receptor
infect
experi
wildtyp
bkv
construct
mutant
show
result
receptor
unavail
gag
use
altern
receptor
infect
cell
type
find
provid
better
understand
viru
evolut
switch
receptorbind
specif
trigger
alter
viru
tissuecel
tropism
viru
patholog
understand
critic
diagnosi
treatment
role
sialic
acid
viral
attach
key
first
step
infect
mani
virus
spark
much
interest
character
viral
lectinsia
complex
structur
character
structur
facilit
studi
singl
amino
acid
mutat
mutat
viral
lectin
bind
pocket
investig
biolog
effect
mutat
mutat
better
understand
viru
evolut
variat
receptorbind
specif
import
develop
plan
viral
control
character
complex
structur
also
facilit
studi
modif
sialyl
glycan
structur
bind
viral
lectin
would
pave
way
design
antivir
viral
interact
howev
limit
number
viral
lectinsialyl
glycan
cocrystal
structur
studi
interact
famili
calicivirida
crystal
structur
noroviru
p
lectin
strain
complex
tetrasaccharid
pdb
determin
sia
residu
far
bind
site
particip
bind
viru
thu
classifi
lewi
carbohydratebind
viru
siabind
viru
thu
interact
sialyl
glycan
viral
lectin
orthomyxovirida
human
influenza
ha
trimer
paramyxovirida
mump
hn
tetram
coronavirida
porcin
toroviru
picornavirida
reovirida
reoviru
trimer
reovirida
reoviru
trimer
adenovirida
fiber
trimer
parvovirida
aav
monom
polyomavirida
pentam
analyz
use
pymol
illustr
fig
pdb
structur
inform
shown
tabl
shown
fig
interact
receptorbind
site
locat
head
human
ha
pentasaccharid
lstc
human
respiratori
receptor
analog
indic
neg
charg
direct
hydrogen
bond
interact
chang
nonhydroxyl
phe
chang
neg
charg
asp
found
hemagglutinin
make
lack
abil
bind
neg
charg
sia
well
known
critic
determin
receptorbind
specif
linkag
differ
contain
critic
determin
linkag
human
ha
bind
directli
provid
direct
hydrogen
bond
contact
long
receptor
found
human
bronchu
rare
human
alveoli
crystal
structur
mump
hn
complex
trisaccharid
determin
wherea
cocryst
structur
detect
indic
mump
hn
bind
effici
linkag
differ
sialyl
linkag
bind
prefer
human
mump
hn
human
influenza
indic
analysi
sialyl
glycan
express
mump
target
site
includ
human
parotid
gland
epitheli
cell
need
clarifi
differ
tissu
tropism
virus
bound
arginin
triad
wherea
compound
form
hydrogen
bond
top
pocket
hn
head
domain
interact
suggest
third
sugar
sialyl
glycan
import
part
receptor
determin
mump
viru
studi
receptorbind
specif
viru
use
glycan
variat
asialo
portion
provid
insight
key
bind
determin
requir
mump
infect
current
known
interact
suggest
analog
may
develop
mump
inhibitor
structur
esterasedefici
ptov
mutant
strain
markelo
complex
synthet
receptor
show
receptor
ligand
ha
lectin
domain
r
receptorbind
site
top
homodim
form
hydrogen
bond
four
amino
acid
residu
r
domain
one
residu
esteras
e
domain
studi
substrat
specif
enzymat
deoacetyl
ptov
btov
he
indic
ptov
prefer
sia
wherea
btov
catalyz
mono
dioacetyl
sia
substrat
assum
esteras
ha
lectin
pocket
coevolv
ptov
receptorbind
site
seem
bind
exclud
sia
observ
synthet
receptor
receptorbind
pocket
esterasedefici
ptov
indic
receptorbind
domain
ptov
bind
possibl
oacetyl
group
obstruct
assumedli
side
chain
near
glycerol
side
chain
howev
differ
ptov
btov
esterasesubstr
specif
indic
viral
protein
adapt
host
analysi
glycan
profil
host
mucin
host
target
cell
midjejunum
distal
ileum
togeth
amino
acid
sequenc
direct
receptorbind
assay
esterasesubstr
specif
assay
lead
understand
hostdriven
viral
evolut
interact
hostspecif
protein
torovirus
oacetyl
sia
crystal
sever
commerci
avail
sialyloligosaccharid
differ
glycan
composit
linkag
includ
lstc
sialyllex
dslnt
reveal
viru
preferenti
bind
disialyllactontetraos
dslnt
hexasaccharid
carri
termin
weak
bind
glycan
sialyllex
undetect
bind
glycan
branch
glycan
figur
show
crystal
structur
soak
dslnt
dslnt
found
shallow
bind
site
tip
crown
viral
capsid
protein
viru
shell
form
hydrogen
bond
recent
shown
respons
emerg
pandem
also
shown
provid
hydrogen
bond
format
clockwis
rotat
cw
form
due
flexibl
structur
shown
crystal
structur
complex
complex
shown
fig
fig
respect
crystal
show
elong
trimer
fiber
outercapsid
protein
carri
siabind
site
differ
region
head
domain
bodi
domain
structur
complex
trisaccharid
indic
sugar
form
hydrogen
bond
lactos
moieti
trisaccharid
make
contact
bind
pocket
crystal
structur
complex
shown
reveal
addit
termin
moieti
termin
galnac
moieti
provid
addit
optim
contact
via
van
der
waal
interact
bind
pocket
suggest
addit
galnac
termin
play
import
role
contact
bind
pocket
explain
higher
bind
prefer
glycan
array
bind
assay
differ
interact
structur
pocket
adopt
topolog
differ
topolog
seen
pocket
two
key
set
residu
direct
hydrogen
bond
anchor
make
optim
contact
third
glc
demonstr
differ
bind
prefer
sialyl
glycan
contribut
differ
tropism
virus
cn
newborn
mice
studi
reoviru
pathogenesi
viru
mainli
found
ependym
cell
wherea
viru
commonli
found
neuron
also
find
may
use
manipul
virus
specif
infect
target
cell
therapeut
applic
knob
bind
immobil
gangliosid
includ
glycan
part
dock
knob
thought
bind
glycan
partlik
structur
glycoprotein
rather
gangliosid
crystal
structur
fiber
knob
complex
oligosaccharid
determin
figur
show
specif
interact
oligosaccharid
trimer
fiber
capsid
protein
protrud
anoth
capsid
protein
penton
base
two
termin
moieti
glycan
found
differ
protom
shown
salmon
sky
blue
color
siabind
site
knob
knob
residu
protom
provid
direct
hydrogen
bond
format
termin
one
protom
sky
blue
color
also
provid
indirect
hydrogen
bond
format
via
water
molecul
shown
silico
substitut
ala
suggest
vitro
experi
confirm
crucial
role
siabind
specif
knob
mutat
lead
almost
complet
abolish
bind
knob
cell
indic
abil
protein
bind
sia
cell
surfac
import
knobcel
bind
import
sia
infect
verifi
infect
human
corneal
epitheli
cell
decreas
presenc
multival
sia
conjug
human
serum
albumin
compar
presenc
monoval
siaconjug
inhibitor
find
highlight
possibl
develop
multival
siacontain
antivir
drug
specif
treatment
conjunctiv
corneal
cell
crystal
soak
trisaccharid
top
hit
glycan
bound
determin
glycan
array
neg
charg
carboxyl
termin
found
form
hydrogen
bond
residu
siabind
pocket
base
protrus
monom
fig
residu
near
consid
provid
potenti
bind
contact
interact
use
inform
ration
structur
engin
vector
total
residu
differ
order
improv
therapeut
efficaci
exampl
sitedirect
mutagenesi
substitut
residu
form
siabind
pocket
indic
mutant
increas
bind
sia
one
six
residu
differ
shown
purpl
stick
fig
appear
respons
bind
abil
heparin
sulfat
proteoglycan
hspg
bind
abil
one
factor
contribut
differ
tissu
tropism
tabl
two
virus
glycan
array
screen
synthet
physiolog
relev
oligosaccharid
oligosaccharid
produc
highest
bind
signal
recombinantli
produc
capsid
protein
oligosaccharid
found
shallow
groov
capsid
outer
surfac
crystal
oligosaccharid
fig
clearli
two
critic
set
amino
acid
residu
directli
interact
gal
termin
via
hydrogen
bond
format
directli
form
hydrogen
bond
termin
stem
oligosaccharid
interact
use
model
comparison
sialyl
interact
jcpyv
bkpyv
virus
famili
close
relat
amino
acid
ident
among
protein
three
virus
studi
cellular
tropism
exampl
structur
comparison
one
termin
one
gal
termin
interact
bkpyv
one
termin
interact
suggest
amino
acid
posit
may
regul
select
oligosaccharid
affin
appear
singl
point
mutat
site
ly
bkpyv
ser
enabl
bkpyv
chang
bind
prefer
oligosaccharid
confirm
vitro
bind
assay
cell
cultur
find
highlight
plastic
viral
bind
site
lead
chang
receptorbind
specif
could
trigger
chang
cellular
tropism
pathogen
howev
futur
interact
may
use
design
antivir
drug
infect
due
increas
report
associ
human
cancer
includ
human
brain
tumor
bone
cancer
malign
mesothelioma
nonhodgkin
lymphoma
sialoglycoprotein
andor
gangliosid
import
infect
pathogenesi
transmiss
sever
envelop
nonenvelop
virus
use
spike
glycoprotein
viral
capsid
protein
respect
viral
siabind
lectin
viral
siabind
lectin
may
bind
siacontain
materi
mucu
order
persist
pass
environ
transmiss
grasp
host
cell
surfac
sia
like
doorknob
either
sole
primari
coreceptor
lead
open
host
plasma
endosom
membran
allow
releas
viral
genom
host
cell
multipl
siabind
therapeut
virus
use
prevent
andor
treatment
anim
human
diseas
siabind
pathogen
continu
threaten
health
life
human
andor
econom
anim
epidem
andor
pandem
includ
influenza
virus
develop
effect
specif
siabind
therapeut
virus
effect
control
siabind
pathogen
review
histori
recent
data
sialyl
glycan
bind
virus
sia
gener
tabl
siabind
virus
give
roadmap
primarili
display
link
viral
lectin
siabind
prefer
diseas
host
rang
tissu
tropism
entri
pathway
attempt
identifi
similar
differ
virus
well
still
unknown
need
studi
remark
envelop
virus
famili
orthomyxovirida
paramyxovirida
coronavirida
sia
receptorbind
activ
sia
receptordestroy
enzym
rde
activ
virus
function
molecul
other
function
separ
molecul
siabind
envelop
merscov
tgev
nonenvelop
virus
even
though
genu
siadenoviru
contain
put
sialidas
homologu
gene
function
known
encod
rde
virus
releas
trap
decoy
sia
receptor
mucin
influenza
virus
must
acquir
abil
bind
humantyp
receptor
effici
transmiss
among
human
na
influenza
virus
keep
cleavag
specif
virus
releasedspread
mucin
infect
cell
studi
receptorbind
receptordestroy
structur
function
evolut
could
lead
answer
consequ
open
avenu
effici
control
viru
spreadtransmiss
addit
summar
sialyl
glycanbind
prefer
virus
associ
glycan
present
tissu
exampl
tgev
swine
intestin
viru
prefer
bind
present
pig
humanadapt
virus
influenza
virus
reduc
prefer
bind
rare
detect
normal
human
tissu
target
siabind
virus
often
eye
respiratori
system
intestin
nervou
system
impli
organ
contain
high
level
sia
thu
identif
sialyl
glycan
structur
viral
receptor
tissu
variou
anim
lead
understand
viral
host
tissu
tropism
virus
broad
rang
host
influenza
virus
coronavirus
emcv
calicivirus
rotavirus
zoonot
potenti
surveil
virus
maintain
plan
respons
newli
emerg
zoonot
diseas
made
import
realiz
state
differ
viru
infect
may
caus
diseas
red
eye
possibl
caus
influenza
virus
hadvd
entri
pathway
siabind
envelop
virus
direct
fusion
host
plasma
membran
fusion
endosom
membran
entri
pathway
siabind
nonenvelop
virus
endocytosi
follow
endosom
permeabilizationlysi
result
proteolysi
andor
capsid
conform
chang
picornavirus
calicivirus
reovirus
adenovirus
lipolysi
parvovirus
follow
erad
pathway
polyomavirus
except
emcv
possibl
direct
penetr
genom
plasma
membran
molecular
structur
studi
indic
siabind
site
usual
head
viral
lectin
except
reoviru
capsid
protein
strain
carri
siabind
site
bodi
remain
unknown
siabind
site
bodi
head
wherea
jamabind
site
virus
head
integr
analys
similar
differ
siabind
virus
field
viral
glycan
interact
provid
use
data
design
develop
new
tool
combat
pathogen
infect
improv
therapeut
virus
therapeut
applic
follow
mani
simpl
test
establish
detect
chang
viral
receptorbind
prefer
virus
pandem
potenti
viral
nabas
detect
immunochromatographicbas
detect
detect
indic
whether
virus
present
clinic
sampl
bind
specif
receptor
due
possibl
coinfect
siabind
pathogen
sampl
especi
poultri
stool
sampl
improv
method
detect
develop
tag
label
expect
individu
virus
sampl
need
receptorbindingbas
diagnost
method
abl
identifi
viru
level
famili
genu
subtyp
speci
strain
specif
inform
current
detect
method
viral
identif
surveil
pandem
prepared
treatment
viral
lectin
potenti
target
requir
crucial
first
stage
viru
life
cycl
sever
antivir
lectin
develop
act
common
pathogen
caus
widespread
sever
lifethreaten
diseas
human
sialylmimet
rotaviru
infect
trival
sialic
acidbas
inhibitor
treat
infect
pga
chain
acid
influenza
epidem
pandem
virus
siaindepend
virus
rotaviru
human
strain
ku
mo
wa
strain
siabind
pathogen
merscov
jcpyv
mcpyv
use
one
receptor
infect
also
virus
includ
bkpyv
jcpyv
famili
polyomavirida
use
altern
receptor
infect
fact
taken
consider
drug
design
treatment
addit
sialyl
glycan
import
host
siadepend
virus
antivir
drug
design
thu
select
viral
lectin
compar
counterpart
host
lectin
order
reduc
host
toxic
treatment
use
antivir
lectin
pga
inhibit
influenza
infect
via
inhibit
influenza
lectin
attach
cell
surfac
sia
receptor
appear
synerg
either
two
fda
food
drug
administr
approv
na
inhibitor
oseltamivir
carboxyl
zanamivir
suggest
antivir
lectin
may
use
combin
antivir
receptordestroy
enzym
antinaantiesteras
power
inhibitori
activ
minim
toxic
delay
develop
resist
potenti
treatment
compound
mumefur
deriv
sialyl
distearoylphosphatidylethanolamin
inhibit
influenza
viru
infect
via
inhibit
ha
na
function
suggest
molecul
dual
inhibitori
function
bind
releas
design
new
antivir
chemotyp
differ
virus
caus
infect
cell
share
siabind
specif
exampl
hadvd
bind
infect
corneal
cell
glycan
thu
possibl
design
develop
broadspectrum
siabas
antivir
drug
siabind
pathogen
infect
cell
chines
say
use
enemi
kill
enemi
siabind
virus
ndv
reovirus
adenoviru
vector
pseudotyp
fiber
hadvd
aav
investig
treatment
human
diseas
base
oncolyt
properti
preferenti
infect
lyse
cancer
cell
socal
oncolyt
virotherapi
reoviru
develop
pelareorep
approv
fda
treatment
malign
glioma
treatment
metastat
breast
cancer
continu
investig
treatment
cancer
cell
prolif
disord
includ
malign
melanoma
lack
pathogen
aav
allow
extens
investig
genetherapi
vector
call
viral
gene
therapi
alipogen
tiparvovec
develop
vector
approv
european
commiss
treatment
famili
lipoprotein
lipas
defici
lpld
adult
patient
sever
pancreat
despit
strict
lowfat
diet
normal
low
abund
viral
receptor
abnorm
cell
need
treat
key
limit
use
oncolyt
virus
viral
vector
treat
human
diseas
thu
modif
virus
effici
bind
receptor
present
target
cell
critic
viru
infect
typic
siabind
therapeut
virus
includ
reovirus
aav
vector
pseudotyp
hadvd
fiber
one
bind
site
bind
sia
receptor
anoth
receptor
design
therapeut
viru
effici
bind
least
two
receptor
may
help
prevent
mutat
host
receptor
escap
viral
transfectiontransduct
also
viru
effici
bind
two
receptor
could
effici
infect
host
cell
transmit
specif
among
target
host
cell
evid
addit
use
essenti
receptor
emerg
caus
ahc
pandem
adapt
effici
bind
sia
attach
receptor
support
infect
also
shown
siadepend
rotaviru
strain
grow
effici
siaindepend
rotaviru
strain
siacontain
cell
thu
analysi
receptor
structur
host
cell
need
treat
experi
viru
bind
prefer
sialyl
glycan
structur
found
host
cell
xray
crystallograph
studi
glycan
interact
coupl
structureguid
mutagenesi
need
provid
blueprint
engin
viral
protein
bind
effici
specif
sialyl
glycan
target
host
cell
increas
virussia
receptor
affin
cooper
receptor
bind
target
cell
could
confin
viru
specif
plasma
membran
target
cell
increas
viral
entri
effici
final
although
virus
abil
adapt
environ
continu
sustain
improv
surveillancediagnost
tool
antivir
would
lead
erad
viral
pathogen
case
smallpox
viru
declar
erad
sinc
continu
improv
research
technolog
possibl
gener
recombin
therapeut
virus
effici
bind
dual
receptor
synergist
intern
target
cell
could
prevent
chang
cellular
protein
resist
viru
entri
reduc
undesir
toxic
normal
cell
increas
target
cell
specif
transfectiontransduct
effici
lead
improv
virus
treatment
anim
human
diseas
